William John Thomas serves as Executive at CYTOGEN CORP, where they oversee executive responsibilities. Since joining the company, William John Thomas has executed 10 insider transactions totaling $3.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 9, 2011 involved transacting 1,000 shares valued at $2.8K.
William John Thomas currently holds 900 shares of CYTOGEN CORP (CYTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William John Thomas has been a net buyer of CYTO stock. They have purchased $3.2K and sold $0 worth of shares.
William John Thomas's most recent insider trade was on Dec 9, 2011, when they sold 1,000 shares at $2.80 per share.
Get notified when new Form 4 filings are submitted
| $3.27 |
| Discretionary |
| Aug 6, 2008 | ORCH | $329 | Purchase | 100 | $3.29 | Discretionary |
| Aug 6, 2008 | ORCH | $640 | Purchase | 200 | $3.20 | Discretionary |
| Aug 6, 2008 | ORCH | $321 | Purchase | 100 | $3.21 | Discretionary |
| Aug 6, 2008 | ORCH | $323 | Purchase | 100 | $3.23 | Discretionary |
| Aug 6, 2008 | ORCH | $978 | Purchase | 300 | $3.26 | Discretionary |
| Feb 20, 2007 | CYTO | $40.0K | Award | 16,000 | $2.50 | Discretionary |
| Oct 17, 2006 | CYTO | $0 | Award | 15,000 | $N/A | Discretionary |
| Apr 4, 2006 | CYTO | $0 | Award | 8,100 | $N/A | Discretionary |